Mera Pharmaceuticals, Inc. (MRPI)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Aug 15, 2025
Mera Pharmaceuticals Market Cap
Mera Pharmaceuticals has a market cap or net worth of $53.67 thousand as of August 22, 2025. Its market cap has decreased by -99.25% in one year.
Market Cap
53.67K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since August 2, 1993, Mera Pharmaceuticals's market cap has decreased from 1.56M to 53.67K, a decrease of -96.55%. That is a compound annual growth rate of -9.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 53.67K | -3.62% |
| Dec 30, 2022 | 55.68K | -50.00% |
| Dec 31, 2021 | 111.36K | -95.83% |
| Dec 31, 2020 | 2.67M | 1,100.00% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 632.06M |
| Elite Pharmaceuticals | 587.83M |
| American Oncology Network | 382.44M |
| CytoDyn | 372.33M |
| Northwest Biotherapeutics | 366.64M |